Melphalan Pregnancy and Breastfeeding Warnings
Melphalan is also known as: Alkeran
Melphalan Pregnancy Warnings
Melphalan has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of embryolethality and teratogenicity. There are no controlled data in human pregnancy. Melphalan has been reported to cause suppression of ovarian function in premenopausal women, resulting in amenorrhea in a significant number of patients. Both reversible and irreversible testicular suppression have also been reported. Melphalan should only be given during pregnancy when there are no alternatives and benefit outweighs risk. If this drug is used during pregnancy or if the patient becomes pregnant while receiving the drug, she should be made aware of the potential hazard to the fetus. Women of childbearing potential should be advised to avoid becoming pregnant.
Melphalan Breastfeeding Warnings
There are no data on the excretion of melphalan into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to melphalan in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
- melphalan Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.